Patheon Leaders to Attend DCAT Week

Durham, N.C.  — (March 11, 2015) Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sector, will participate at DCAT Week 2015 in New York, March 16-19.

Patheon recently announced two acquisitions in support of the company’s business strategy to enter into logical adjacencies and drive industry consolidation. Patheon offerings now include North American API development and manufacturing services with the addition of IRIX Pharmaceuticals and a solubility center of excellence with the acquisition of Agere Pharmaceuticals.

As part of DCAT week, Patheon will be honored at the CMO Leadership Awards reception and ceremony hosted by Life Science Leader for the company’s achievements in innovation with emerging pharma. This is the fifth year in a row that Patheon has been recognized for innovation. The CMO Leadership Awards are based on industry research conducted by Nice Insight, a marketing research and intelligence group. The awards recognize companies ranked in the top 10 percent in five perception categories: quality, productivity, reliability, innovation and regulatory by company type.

DCAT Week is one of the largest gatherings for the pharmaceutical and related industries in the world. Its unique model brings industry CEOs, presidents, global sales managers and directors of supply chain management from around the globe for high-level meetings, strategy sessions, education programs and networking events.

About Patheon

Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector. A leading global provider with more than 8,000 employees worldwide, Patheon has a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. For more information, visit


Patheon Media Relations

Tel: +1 (919) 210-0986

Email: or